The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluating the prognostic significance of lymphovascular invasion in stage II and III colon cancer.
 
Dorotea Mutabdzic
No Relationships to Disclose
 
Shalana BL O'Brien
No Relationships to Disclose
 
Elizabeth A. Handorf
Research Funding - Pfizer (Inst); Pfizer (Inst); Pfizer (Inst)
 
Karthik Devarajan
Stock and Other Ownership Interests - AstraZeneca; Bristol-Myers Squibb
 
Sanjay S. Reddy
No Relationships to Disclose
 
Elin R. Sigurdson
No Relationships to Disclose
 
Crystal S. Denlinger
Consulting or Advisory Role - Bristol-Myers Squibb; Carevive Systems; EMD Serono; Lilly; Merck
Research Funding - Advaxis (Inst); Agios (Inst); Array BioPharma (Inst); AstraZeneca (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Incyte (Inst); Lilly (Inst); Macrogenics (Inst); MedImmune (Inst); Merrimack (Inst); OncoMed (Inst)
 
Joshua E. Meyer
No Relationships to Disclose
 
Jeffrey M. Farma
Consulting or Advisory Role - Amgen; Castle Biosciences
Other Relationship - Delcath Systems